HK1056116A1 - Sucrose ester c-20 to c-28 alcohol formulation - Google Patents

Sucrose ester c-20 to c-28 alcohol formulation

Info

Publication number
HK1056116A1
HK1056116A1 HK03108374A HK03108374A HK1056116A1 HK 1056116 A1 HK1056116 A1 HK 1056116A1 HK 03108374 A HK03108374 A HK 03108374A HK 03108374 A HK03108374 A HK 03108374A HK 1056116 A1 HK1056116 A1 HK 1056116A1
Authority
HK
Hong Kong
Prior art keywords
sucrose ester
sucrose
alcohol formulation
formulation
alcohol
Prior art date
Application number
HK03108374A
Other languages
English (en)
Inventor
David H Katz
Mohammed H Khalil
Laura E Pipe
John F Marcelletti
Lee R Katz
Original Assignee
Avanir Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avanir Pharmaceuticals filed Critical Avanir Pharmaceuticals
Publication of HK1056116A1 publication Critical patent/HK1056116A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
HK03108374A 1993-12-13 2003-11-17 Sucrose ester c-20 to c-28 alcohol formulation HK1056116A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16652393A 1993-12-13 1993-12-13

Publications (1)

Publication Number Publication Date
HK1056116A1 true HK1056116A1 (en) 2004-02-06

Family

ID=22603672

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03108374A HK1056116A1 (en) 1993-12-13 2003-11-17 Sucrose ester c-20 to c-28 alcohol formulation

Country Status (15)

Country Link
US (1) US5534554A (xx)
EP (2) EP0738141B1 (xx)
JP (2) JP4149511B2 (xx)
KR (1) KR100322507B1 (xx)
CN (2) CN1103586C (xx)
AT (2) ATE383848T1 (xx)
AU (1) AU693476B2 (xx)
CA (1) CA2156063C (xx)
DE (2) DE69435067T2 (xx)
DK (2) DK0738141T3 (xx)
ES (2) ES2299173T3 (xx)
HK (1) HK1056116A1 (xx)
PT (2) PT1473031E (xx)
SG (1) SG43833A1 (xx)
WO (1) WO1995016434A1 (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2710854B1 (fr) * 1993-10-08 1995-12-01 Oreal Emulsion huile-dans-eau utilisable pour l'obtention d'une crème.
KR100528816B1 (ko) * 1996-09-17 2005-11-16 아바니르 파마슈티컬스 장쇄 알코올, 알칸, 지방산 및 아미드에 의한 바이러스억제 방법
AU780340B2 (en) * 1996-09-17 2005-03-17 Avanir Pharmaceuticals Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides
US5952392A (en) * 1996-09-17 1999-09-14 Avanir Pharmaceuticals Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US5948822A (en) 1996-12-17 1999-09-07 Lidak Pharmaceuticals Treatment of hyperproliferative skin disorders with C18 to C26 alphatic alcohols
AU7735298A (en) * 1996-12-17 1998-07-15 Lidak Pharmaceuticals Use of C18 to C26 aliphatic alcohols for the manufacture of medicament in the t reatment of hyperproliferative skin disorders
DE19718777A1 (de) * 1997-05-03 1998-11-05 Beiersdorf Ag Verwendung von Estern aus Fettsäuren und Di- und Oligosacchariden gegen die Adhäsion von Mikroorganismen
US6046244A (en) * 1997-11-05 2000-04-04 Nexmed Holdings, Inc. Topical compositions for prostaglandin E1 delivery
US6414028B1 (en) 1997-11-05 2002-07-02 Nexmed Holdings, Inc. Topical compositions containing prostaglandin E1
US20050203187A1 (en) * 1998-06-01 2005-09-15 Verbiscar Anthony J. Formulations useful for the treatment of varicella zoster virus infections and methods for the use thereof
ITMI981528A1 (it) * 1998-07-03 2000-01-03 Recordati Ind Chimica E Farma Formulazioni topiche di aciclovir
ES2242582T3 (es) 1999-09-03 2005-11-16 Cabby Business Inc. Procedimiento de alta eficiencia para la preparacion de esteroles de alta pureza.
ES2298197T3 (es) * 2000-01-31 2008-05-16 Harting S.A. Composiciones que contienen esteres de acidos grasos de fitosterol y de policosanol para reducir el colesterol y los trigliceridos de la sangre.
PT102410A (pt) * 2000-02-03 2001-08-30 Qualitas Lab Extraccao da fraccao ceroide do residuo resinoso de fabricacao de aglomerado negro de cortica com fluido supercritico
US7399790B2 (en) 2001-02-28 2008-07-15 Konowalchuk Thomas W Virucidal compositions
JP2005519868A (ja) * 2001-10-16 2005-07-07 アバニール・ファーマシューティカルズ ｎ−ドコサノールによるウイルス阻害
US6559182B1 (en) * 2001-11-07 2003-05-06 Purcell Jojoba International, Llc Method for treatment of enveloped viruses using jojoba oil esters
US7214394B2 (en) * 2002-05-31 2007-05-08 Archer-Daniels-Midland Company Policosanol compositions, extraction from novel sources, and uses thereof
GB0313830D0 (en) * 2003-06-16 2003-07-23 Unichema Chemie Bv Surfactant composition
US20050074443A1 (en) * 2003-10-03 2005-04-07 Treadwell Benjamin V. Methods of attenuating autoimmune disease and compositions useful therefor
PL2132215T3 (pl) 2007-02-28 2016-04-29 Univ Alberta Związki do zapobiegania lub leczenia zakażeń wirusowych i sposoby ich stosowania
US8715715B2 (en) 2008-11-03 2014-05-06 Nal Pharmaceuticals Ltd. Dosage form for insertion into the mouth
US20100209484A1 (en) * 2009-02-13 2010-08-19 Hoo-Kyun Choi Transdermal Triptan Delivery System
FR2949329B1 (fr) * 2009-08-31 2011-10-21 Oreal Composition cosmetique comprenant un alcane lineaire volatil et un ester de sucrose
CN102049050B (zh) * 2009-11-02 2014-06-18 重庆华邦制药有限公司 抗疱疹病毒感染的药物组合物
GB201207781D0 (en) 2012-05-03 2012-06-13 Restoration Of Appearance And Function Trust Extracellular matrix - synthetic skin scaffold
CN103877019B (zh) * 2013-10-31 2016-01-06 湖北科益药业股份有限公司 一种二十二醇乳膏
CN116583264A (zh) * 2020-12-14 2023-08-11 宝洁公司 包含蔗糖酯和溶剂的化妆品组合物
EP4259068A1 (en) * 2020-12-14 2023-10-18 The Procter & Gamble Company Method of manufacturing cosmetic compositions comprising sucrose esters and solvents

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1459233A (en) * 1973-08-29 1976-12-22 Inst Rech Chim Biolog Medicament containing a higher alkanol
US4200655A (en) * 1978-08-15 1980-04-29 Sterling Drug Inc. Benzyl alcohol virucidal process
FR2492829A1 (fr) * 1980-10-24 1982-04-30 Oreal Agents de surface non-ioniques derives du glucose, procede pour les preparer et compositions les contenant
US4536519A (en) * 1981-06-15 1985-08-20 Kao Soap Co., Ltd. Emulsifying agent and emulsified cosmetics
US4670471A (en) * 1981-11-03 1987-06-02 Clark Lealand L Treatment for inflammatory skin disease
DE3348500C2 (de) * 1982-05-28 1998-10-22 Eisai Co Ltd beta,gamma-Dihydropolyprenylalkoholderivat
ATE81449T1 (de) * 1984-03-05 1992-10-15 Tonfer Inc Reinigungsmittel.
US4684479A (en) * 1985-08-14 1987-08-04 Arrigo Joseph S D Surfactant mixtures, stable gas-in-liquid emulsions, and methods for the production of such emulsions from said mixtures
JPH0816066B2 (ja) * 1986-07-18 1996-02-21 エーザイ株式会社 持続性薬効製剤
JPS63179817A (ja) * 1987-01-19 1988-07-23 Kobayashi Kooc:Kk 水性クレンジング料
US4900555A (en) * 1987-02-26 1990-02-13 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US4940586A (en) * 1987-02-26 1990-07-10 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US4865848A (en) * 1987-02-26 1989-09-12 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US4874794A (en) * 1989-04-28 1989-10-17 Lidak Biopharmaceuticals Inflammatory disease treatment
US5070107A (en) * 1989-04-28 1991-12-03 Lidak Pharmaceuticals Systemic antiviral treatment
US4956171A (en) * 1989-07-21 1990-09-11 Paco Pharmaceutical Services, Inc. Transdermal drug delivery using a dual permeation enhancer and method of performing the same
US5166219A (en) * 1989-11-02 1992-11-24 Lidak Pharmaceuticals Systemic anti-inflammatory treatment
US5194451A (en) * 1989-11-02 1993-03-16 Katz David H Systemic anti-inflammatory treatment
JPH03157349A (ja) * 1989-11-14 1991-07-05 Lion Corp 乳化組成物
US5214071A (en) * 1991-04-23 1993-05-25 Summit Technology, Inc. Corneal treatment agents
US5098896A (en) * 1991-04-23 1992-03-24 Summit Technology, Inc. Corneal treatment agents
GB9204388D0 (en) * 1992-02-29 1992-04-15 Tioxide Specialties Ltd Water-in-oil emulsions

Also Published As

Publication number Publication date
DE69435067T2 (de) 2008-05-15
EP0738141A1 (en) 1996-10-23
CA2156063C (en) 1999-06-29
PT738141E (pt) 2008-02-11
CN1103586C (zh) 2003-03-26
KR100322507B1 (ko) 2002-08-14
DE69435067D1 (de) 2008-03-06
EP1473031A1 (en) 2004-11-03
JP4149511B2 (ja) 2008-09-10
CN1419911A (zh) 2003-05-28
AU693476B2 (en) 1998-07-02
CN1223342C (zh) 2005-10-19
DK1473031T3 (da) 2008-10-20
ES2299173T3 (es) 2008-05-16
EP0738141B1 (en) 2008-01-16
PT1473031E (pt) 2008-08-05
CN1142764A (zh) 1997-02-12
ES2309441T3 (es) 2008-12-16
WO1995016434A1 (en) 1995-06-22
EP0738141A4 (en) 1998-01-07
DK0738141T3 (da) 2008-05-19
ATE383848T1 (de) 2008-02-15
SG43833A1 (en) 1997-11-14
DE69435106D1 (de) 2008-08-07
EP1473031B1 (en) 2008-06-25
ATE399004T1 (de) 2008-07-15
CA2156063A1 (en) 1995-06-22
JP2006206610A (ja) 2006-08-10
JPH09506612A (ja) 1997-06-30
AU7719294A (en) 1995-07-03
US5534554A (en) 1996-07-09

Similar Documents

Publication Publication Date Title
HK1056116A1 (en) Sucrose ester c-20 to c-28 alcohol formulation
DE68921688D1 (de) Wenig reizendes Reinigungsmittel.
HU9302462D0 (en) Pesticidal preparatives containing fluorine-alkenyl compounds
ES2033259T3 (es) Bases de liberacion controlada de productos farmaceuticos.
FI891552A0 (fi) Anti-inflammatorisk emulsionssalvakomposition.
EP0667330A4 (xx)
AU626749B2 (en) Transparent cosmetic composition containing glycerol, soap, and soap crystal growth inhibitor
ATE150075T1 (de) Detergenzusammensetzung
IT1114215B (it) Composizione a base di perossidi liquida
IT1144059B (it) Composizione tensioattiva a base di alcossi-bis(tialcossisilossi)silano a basso schiumeggiamento
DK0556424T3 (da) Fremgangsmåde til affarvning af fedtsyreester, samt levnedsmiddel og kosmetisk præparat med en sådan affarvet ester
AU571071B2 (en) Salicylic acid ester perfume compositions
GB8809027D0 (en) Carbonylation of allylic alcohols
DK0407815T3 (da) Præparat indeholdende polyprenylforbindelser til bløde kapsler
ES2069765T3 (es) Nuevos derivados del acido 2,2-dimetil-ciclopropenocarboxilico que llevan en posicion 3 una cadena halogenada saturada, su procedimiento de preparacion y su aplicacion en la sintesis de productos plaguicidas.
FI885708A0 (fi) Foerfarande foer metylering av xantiner.
JPS5441385A (en) Ester synthesis of terpene alcohol by lypase
DE3864509D1 (de) Alkoventrennung.
FR2370743A1 (fr) Preparation de trans-hexahydrodibenzopyranones
JPS5414924A (en) Preparation of (-)-cis-1,2-epoxypropylphosphonic acid derivative
JPS543040A (en) Preparation of bisabolene
UA11669A1 (uk) Стимулятор росту сіяhців сосhи звичайhої
KR900015583U (ko) 경운기의 조작레버구조
DK0479431T3 (da) Mellemprodukter for 1-carbacephalosporiner og fremgangsmåde til fremstilling heraf
JPS53135917A (en) Preparation of 3,3-dimethyl-1-hexen-5-one

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20140901